# Eagle Pharmaceuticals (EGRX) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/EGRX
## Company Profile
- Ticker: EGRX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 0.75 USD
- Market cap: Not available USD
- Last updated: 2026-09-03
## Business Overview
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on hospital and acute-care products. Its business has historically centered on commercialization of focused injectable or hospital-based medicines.
## Why The Stock Is Moving

Current closing-price context is not available for EGRX.

## Geographic Base

Eagle is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and hospital care.

## Business Model

The company depends on product sales, hospital access, and portfolio management. Investors usually watch revenue, execution, and strategic changes.

## Landscape Position

Eagle occupies a hospital-specialty niche within pharma. It is more commercial than development-stage biotech and tends to respond to product and portfolio developments.

## Future Catalysts

- Eagle’s catalysts are hospital-product execution and any portfolio update that clarifies the company’s growth path. The market cares about recurring demand and margin discipline.

## Recent News
- 2026-01-14 15:21 EST — [Eagle Pharmaceuticals Announces Divestiture of Barhemsys](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-divestiture-of-barhemsys) — Source: Eagle Pharmaceuticals
- 2025-10-30 10:50 EST — [Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-board-extends-limited-duration-stockholder-rights-plan) — Source: Eagle Pharmaceuticals
- 2025-10-21 20:05 EST — [Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-results-of-2025-annual-meeting-of-stockholders) — Source: Eagle Pharmaceuticals
- 2025-10-15 20:30 EST — [Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-availability-of-unaudited-second-quarter-2025-financial-statements) — Source: Eagle Pharmaceuticals
- 2025-10-06 23:30 EST — [Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements](https://biopharmsignal.com/news/EGRX/eagle-pharmaceuticals-announces-availability-of-unaudited-first-quarter-2025-financial-statements) — Source: Eagle Pharmaceuticals